Convergent hybrid ablation is an innovative treatment for a type of irregular heart rhythm called atrial fibrillation (AFib). The treatment is a two-stage procedure that combines the expertise of our ...

Using real-world data, researchers found that 81.6% of patients were free from AFib one year after RF-based ablation - a higher percentage than attained in clinical trials.

Among patients with atrial fibrillation who chose to undergo catheter ablation, those who lost at least 3% of body weight before the procedure were more likely to be free from AF at 6 months ...

Catheter ablation for atrial fibrillation (Afib) is safe and suppresses arrhythmia recurrences in 74% of patients after a single procedure, according to new results. The survey also showed that ...

Atrial fibrillation is a common arrhythmia that affects an estimated 30 million people worldwide. New research shows that catheter ablation, a common cardiovascular procedure, appears no more ...

Using catheter-based ablation instead of medications alone reduces the risks of death and stroke in patients with the common form of heart arrhythmia known as atrial fibrillation, or AFib, new ...

London, United Kingdom – 2 September 2024: A catheter ablation procedure widely used to treat the most common heart rhythm disorder significantly reduces the burden of atrial fibrillation (AF ...

At 1 year, according to the ESC-EHRA Atrial Fibrillation Ablation Long-Term registry, the procedure was associated with a success rate of 73.6% -- the proportion of patients surviving free from ...

The Centers for Disease Control and Prevention estimate that more than 12 million people in the U.S. will be diagnosed with afib in 2030—and developers of heart ablation procedures have been ...